RESUMO
Aquaporins (AQPs) are water-specific membrane channel proteins that regulate cellular and organismal water homeostasis. The nose, an organ with important respiratory and olfactory functions, is the first organ exposed to external stimuli. Nose-related topics such as allergic rhinitis (AR) and chronic rhinosinusitis (CRS) have been the subject of extensive research. These studies have reported that mechanisms that drive the development of multiple inflammatory diseases that occur in the nose and contribute to the process of olfactory recognition of compounds entering the nasal cavity involve the action of water channels such as AQPs. In this review, we provide a comprehensive overview of the relationship between AQPs and rhinologic conditions, focusing on the current state of knowledge and mechanisms that link AQPs and rhinologic conditions. Key conclusions include the following: (1) Various AQPs are expressed in both nasal mucosa and olfactory mucosa; (2) the expression of AQPs in these tissues is different in inflammatory diseases such as AR or CRS, as compared with that in normal tissues; (3) the expression of AQPs in CRS differs depending on the presence or absence of nasal polyps; and (4) the expression of AQPs in tissues associated with olfaction is different from that in the respiratory epithelium.
Assuntos
Aquaporinas/metabolismo , Doenças Nasais/metabolismo , Animais , Humanos , Inflamação/patologia , Mucosa Nasal/metabolismo , Mucosa Nasal/patologia , Mucosa Nasal/fisiopatologia , Doenças Nasais/fisiopatologia , OlfatoRESUMO
Hereditary nasal parakeratosis (HNPK) is an inherited disorder described in Labrador Retrievers and Greyhounds. It has been associated with breed-specific variants in the SUV39H2 gene encoding a histone 3 methyltransferase involved in epigenetic silencing. Formalin-fixed biopsies of the nasal planum of Labrador Retrievers were screened by immunofluorescence microscopy for the presence and distribution of epidermal proliferation and differentiation markers. Gene expression of these markers was further analysed using RNA sequencing (RNA-seq) and ultrastructural epidermal differences were investigated by electron microscopy. Differentiation of the nasal planum in the basal and suprabasal epidermal layers of HNPK-affected dogs (n = 6) was similar compared to control dogs (n = 6). In the upper epidermal layers, clear modifications were noticed. Loricrin protein was absent in HNPK-affected nasal planum sections in contrast to sections of the same location of control dogs. However, loricrin was present in the epidermis of paw pads and abdominal skin from HNPK dogs and healthy control dogs. The patterns of keratins K1, K10 and K14, were not markedly altered in the nasal planum of HNPK-affected dogs while the expression of the terminal differentiation marker involucrin appeared less regular. Based on RNA-seq, LOR and IVL expression levels were significantly decreased, while KRT1, KRT10 and KRT14 levels were up-regulated (log2fold-changes of 2.67, 3.19 and 1.71, respectively) in HNPK-affected nasal planum (n = 3) compared to control dogs (n = 3). Electron microscopical analysis revealed structural alterations in keratinocytes and stratum corneum, and disrupted keratinocyte adhesions and distended intercellular spaces in lesional samples (n = 3) compared to a sample of a healthy control dog (n = 1). Our findings demonstrate aberrant keratinocyte terminal differentiation of the nasal planum of HNPK-affected Labrador Retrievers and provide insights into biological consequences of this inactive SUV39H2 gene variant.
Assuntos
Antígenos de Diferenciação , Doenças do Cão , Doenças Genéticas Inatas , Doenças Nasais , Paraceratose , Animais , Cães , Feminino , Masculino , Antígenos de Diferenciação/genética , Antígenos de Diferenciação/metabolismo , Doenças do Cão/genética , Doenças do Cão/metabolismo , Doenças do Cão/patologia , Doenças Genéticas Inatas/genética , Doenças Genéticas Inatas/metabolismo , Doenças Genéticas Inatas/patologia , Doenças Genéticas Inatas/veterinária , Queratinócitos/metabolismo , Queratinócitos/patologia , Doenças Nasais/genética , Doenças Nasais/metabolismo , Doenças Nasais/patologia , Doenças Nasais/veterinária , Paraceratose/genética , Paraceratose/metabolismo , Paraceratose/patologia , Paraceratose/veterináriaRESUMO
Respiratory epithelial adenomatoid hamartoma (REAH) and seromucinous hamartoma (SH) are rare tumor-like lesions of the nasal cavity, paranasal sinuses, and nasopharynx. The pathogenesis of REAH/SH is still unclear. Neoplastic proliferation, chronic mechanical irritation, inflammation, or possible embryological tissue misplacement are speculated as possible mechanisms of their development. Low-grade tubulopapillary adenocarcinoma (LGTA) is a rare variant of nonsalivary, nonintestinal type sinonasal adenocarcinoma. The aim of this study was to evaluate the immunohistochemical and genetic profiles of 10 cases of REAH/SH, with serous, mucinous, and respiratory components evaluated separately and to compare these findings with the features of 9 cases of LGTA. All cases of REAH/SH and LGTA were analyzed immunohistochemically with a cocktail of mucin antigens (MUC1, MUC2, MUC4, MUC5AC, MUC6) and with epithelial (CK7, CK20, CDX2, SATB2) and myoepithelial markers (S100 protein, p63, SOX10). The next-generation sequencing assay was performed using FusionPlex Solid Tumor Kit (ArcherDx) in 10 cases of REAH/SH, and the EGFR-ZNF267 gene fusion was detected in 1 of them. Two female REAH/SH cases were assessed for the presence of clonality. Using the human androgen receptor assay, 1 case was proved to be clonal. The serous component of REAH/SH was positive for CK7/MUC1 and SOX10 similarly to LGTA. Although REAH/SH and LGTA are histopathologically and clinically separate entities, the overlap in their morphological and immunohistochemical profiles suggests that REAH/SH might be a precursor lesion of LGTA.
Assuntos
Adenocarcinoma/diagnóstico , Biomarcadores Tumorais , Hamartoma/diagnóstico , Imuno-Histoquímica , Técnicas de Diagnóstico Molecular , Mucosa Nasal/química , Doenças Nasofaríngeas/diagnóstico , Doenças Nasais/diagnóstico , Neoplasias Nasais/diagnóstico , Lesões Pré-Cancerosas/diagnóstico , Adenocarcinoma/química , Adenocarcinoma/genética , Adenocarcinoma/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/análise , Biomarcadores Tumorais/genética , Criança , Diagnóstico Diferencial , Feminino , Hamartoma/química , Hamartoma/genética , Hamartoma/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Mucosa Nasal/patologia , Doenças Nasofaríngeas/genética , Doenças Nasofaríngeas/metabolismo , Doenças Nasofaríngeas/patologia , Gradação de Tumores , Doenças Nasais/genética , Doenças Nasais/metabolismo , Doenças Nasais/patologia , Neoplasias Nasais/química , Neoplasias Nasais/genética , Neoplasias Nasais/patologia , Lesões Pré-Cancerosas/genética , Lesões Pré-Cancerosas/metabolismo , Lesões Pré-Cancerosas/patologia , Valor Preditivo dos Testes , Adulto JovemRESUMO
BACKGROUND: Although cases of empty nose syndrome (ENS) are not very common, the suffering that ENS causes patient is immense and could be very difficult to imagine. Nasal nitric oxide (nNO) is an airway disease biomarker, and its levels increase after endoscopic sinus surgery. The trend of nNO levels in ENS before and after surgical treatment remains unknown. This study aimed to evaluate the role of nNO in ENS. METHODS: Patients with ENS who received surgical implantation and with chronic hypertrophic rhinitis (CHR) who underwent turbinoplasty and completed at least 1 year of follow-up were prospectively enrolled. nNO measurements and subjective assessments [SinoNasal Outcome Test (SNOT)-22, Beck Depression Inventory (BDI)-II, and Beck Anxiety Inventory (BAI)] were performed preoperatively and at 3, 6, and 12 months postoperatively. RESULTS: We enrolled 19 ENS and 12 CHR patients. nNO levels were significantly lower in the ENS than in the CHR patients before surgical treatment (pâ¯<â¯0.001). nNO levels in the ENS patients significantly increased 3 months after implantation and remained plateaued (pâ¯=â¯0.015). BDI-II and BAI scores significantly improved after surgical treatment for the ENS patients but not for the CHR patients; changes in nNO levels correlated well with improvements in BDI-II and BAI scores (pâ¯=â¯0.025 and 0.035, respectively). CONCLUSIONS: nNO significantly increased at third month after surgical treatment and remained plateaued in ENS patients. This increase correlated with improvements in BDI-II and BAI scores. Therefore, nNO may be important in assessing the psychiatric status of empty nose syndrome.
Assuntos
Óxido Nítrico/metabolismo , Doenças Nasais/metabolismo , Doenças Nasais/psicologia , Nariz/química , Adulto , Idoso , Doença Crônica , Feminino , Humanos , Hipertrofia/diagnóstico , Hipertrofia/metabolismo , Hipertrofia/psicologia , Masculino , Pessoa de Meia-Idade , Óxido Nítrico/análise , Doenças Nasais/diagnóstico , Rinite/diagnóstico , Rinite/metabolismo , Rinite/psicologia , Síndrome , Adulto JovemRESUMO
OBJECTIVES/HYPOTHESIS: Oxymetazoline is an α-adrenergic agonist that is commonly used as a topical hemostatic agent in the operating room during ear, nose, and throat surgery. There are limited data on oxymetazoline pharmacokinetics in children who undergo general anesthesia. We assessed the hemodynamic effects and systemic absorption of topically applied oxymetazoline in children undergoing various nasal procedures. STUDY DESIGN: Prospective trial. METHODS: Children ages 2 to 17 years undergoing functional endoscopic sinus surgery, turbinate resection, or adenoidectomy were enrolled. The surgeon placed oxymetazoline-soaked pledgets (1.5 mL of 0.05% solution) according to our usual clinical practice. Blood samples for oxymetazoline assay were drawn at 5, 10, 20, 45, 90, and 150 minutes, and hemodynamic data were recorded at 5-minute intervals. Data analysis included mixed-effects regression and population pharmacokinetic/pharmacodynamic modeling. RESULTS: The analysis included 27 patients, age 7 ± 4 years, who received between 2 and 12 pledgets (3-18 mL) of oxymetazoline. Relative bioavailability compared to the spray formulation was 2.3 (95% confidence interval [CI]: 1.6-3.2), with slow absorption from the mucosal surface (absorption half-life 64 minutes; 95% CI: 44-90). Mean arterial pressure did not increase with oxymetazoline instillation at the observed oxymetazoline serum concentrations (0.04-7.6 µg/L). CONCLUSIONS: Despite concerns regarding oxymetazoline administration to mucosal membranes, we found that hemodynamic changes were clinically negligible with our usual clinical use of pledgets soaked in oxymetazoline. Compared to data on oxymetazoline in spray formulation, bioavailability was increased twofold with pledgets, but systemic absorption was very slow, contributing to low serum concentrations and limited hemodynamic effects. LEVEL OF EVIDENCE: 1b. Laryngoscope, 129:2775-2781, 2019.
Assuntos
Hemodinâmica/fisiologia , Procedimentos Cirúrgicos Nasais/métodos , Doenças Nasais/cirurgia , Oximetazolina/farmacocinética , Administração Intranasal , Adolescente , Agonistas alfa-Adrenérgicos/administração & dosagem , Agonistas alfa-Adrenérgicos/farmacocinética , Criança , Pré-Escolar , Feminino , Hemodinâmica/efeitos dos fármacos , Humanos , Período Intraoperatório , Masculino , Doenças Nasais/metabolismo , Doenças Nasais/fisiopatologia , Oximetazolina/administração & dosagem , Estudos Prospectivos , Resultado do TratamentoRESUMO
The objective of the present study was to analyse the available data on the qualitative and quantitative composition of nasal secretion (NS) obtained from the healthy subjects and the patients presenting with various diseases of the nose and paranasal sinuses (PHS). The author maintains that investigations for the identification of organic and inorganic components contained in the nasal secretion and for the measurement of their contents as well as the studies of its properties with the use of the biochemical and physical methods are of primary diagnostic and prognostic importance. It is supposed that the physical properties of NS can be described in terms of the notions and principles of rheology. i.e. the science of the flow of matter. For this reason, airway secretion plays an important role in the functioning of the respiratory organs and the maintenance of homeostasis of the internal environment of the body. The composition of secretion from the nasal cavity and paranasal sinuses is considered to be a factor of of pathogenesis and indicator of the pathological processes in the respiratory tract. It is recommended that the adequate mucolytic medicines should be included into the treatment protocol of PNS diseases to liquefy the thick pus and viscous secretion in order to improve the mucociliary clearance and facilitate the release of secretion from the sinuses.
Assuntos
Expectorantes/farmacologia , Microfluídica/métodos , Muco , Mucosa Nasal/metabolismo , Doenças Nasais , Humanos , Depuração Mucociliar/fisiologia , Muco/química , Muco/fisiologia , Doenças Nasais/diagnóstico , Doenças Nasais/tratamento farmacológico , Doenças Nasais/metabolismo , Doenças Nasais/fisiopatologia , Prognóstico , Reprodutibilidade dos Testes , ViscosidadeRESUMO
Respiratory syncytial virus (RSV) infection accounts for approximately 64 million cases of respiratory disease and 200,000 deaths worldwide each year, yet no broadly effective prophylactic or treatment regimen is available. RSV deploys paired, self-associating, heptad repeat domains of its fusion protein, RSV-F, to form a fusogenic 6-helix bundle that enables the virus to penetrate the host cell membrane. Here, we developed hydrocarbon double-stapled RSV fusion peptides that exhibit stabilized α-helical structure and striking proteolytic resistance. Pretreatment with double-stapled RSV peptides that specifically bound to the RSV fusion bundle inhibited infection by both laboratory and clinical RSV isolates in cells and murine infection models. Intranasal delivery of a lead double-stapled RSV peptide effectively prevented viral infection of the nares. A chitosan-based nanoparticle preparation markedly enhanced pulmonary delivery, further preventing progression of RSV infection to the lung. Thus, our results provide a strategy for inhibiting RSV infection by mucosal and endotracheal delivery of double-stapled RSV fusion peptides.
Assuntos
Doenças Nasais/prevenção & controle , Peptídeos , Pneumonia Viral/prevenção & controle , Infecções por Vírus Respiratório Sincicial/prevenção & controle , Vírus Sinciciais Respiratórios , Proteínas Virais de Fusão , Animais , Linhagem Celular , Quitosana/química , Quitosana/farmacologia , Modelos Animais de Doenças , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Nanopartículas/química , Doenças Nasais/metabolismo , Doenças Nasais/patologia , Peptídeos/química , Peptídeos/farmacologia , Pneumonia Viral/metabolismo , Pneumonia Viral/patologia , Infecções por Vírus Respiratório Sincicial/metabolismo , Infecções por Vírus Respiratório Sincicial/patologia , Proteínas Virais de Fusão/química , Proteínas Virais de Fusão/farmacologiaAssuntos
Condrócitos/patologia , Esotropia/diagnóstico , Hamartoma/diagnóstico , Mesoderma/patologia , Doenças Nasais/diagnóstico , Biomarcadores/metabolismo , Condrócitos/metabolismo , Feminino , Hamartoma/metabolismo , Humanos , Técnicas Imunoenzimáticas , Lactente , Imageamento por Ressonância Magnética , Mesoderma/metabolismo , Doenças Nasais/metabolismo , Tomografia por Emissão de Pósitrons , Proteínas S100/metabolismo , Tomografia Computadorizada por Raios XAssuntos
Doenças Nasais , Androstadienos , Doença Crônica , Tomografia Computadorizada de Feixe Cônico/métodos , Ciclo-Oxigenase 2/metabolismo , Ditiotreitol , Fluticasona , Cabeça/fisiologia , Humanos , Imageamento Tridimensional/métodos , Lavagem Nasal/métodos , Doenças Nasais/diagnóstico por imagem , Doenças Nasais/metabolismo , Doenças Nasais/microbiologia , Doenças Nasais/terapia , Neoplasias Nasais/metabolismo , Papiloma Invertido/metabolismo , Rinite/diagnóstico por imagem , Sinusite/diagnóstico por imagem , Sinusite/microbiologiaRESUMO
Membrane type 1 matrix metalloproteinase (MT1-MMP) is implicated in pericellular proteolysis, and, together with tissue inhibitor of matrix metalloproteinases-2 (TIMP-2), in the activation of pro-matrix metalloproteinase-2 on the cell surface. It is expressed on the cell surface either activated or as a proenzyme. A soluble form of MT1-MMP (sMT1-MMP) has been previously identified in periprosthetic tissues and fluid of patients with loose arthroplasty endoprostheses. The aim of this study was to examine periprosthetic tissues and fluids from patients with loose arthroplasty endoprostheses, as well as tissues and fluids from patients with other disorders, for the presence of sMT1-MMP, and to investigate its activation state and possible role. With antibody against MT1-MMP, a protein with molecular mass of ~ 57 kDa was detected by western blotting in all samples tested, representing a soluble form of MT1-MMP, which cannot be ascribed to alternative splicing, as northern blotting showed only one transcript. With various biochemical methods, it was shown that this species occurs in a latent form bearing the N-terminal prodomain, and, additionally, it is bound to TIMP-2, which appeared to be bound via its C-terminal domain to a site different from the active site. Cell ELISA and immunohistochemical analysis revealed that, besides fibroblasts, all other cells, such as inflammatory, epithelial, endothelial, giant and cancer cells, express MT1-MMP on their plasma membrane as a proenzyme. Taking into account the proteolytic abilities of MT1-MMP, the latent sMT1-MMP-TIMP-2 complex could be considered as a new interstitial collagenase. However, the exact role, the production mechanism and the cell origin of this complex remain to be elucidated.
Assuntos
Artroplastia , Prótese do Joelho , Metaloproteinase 14 da Matriz/metabolismo , Líquido Sinovial/química , Inibidor Tecidual de Metaloproteinase-2/metabolismo , Artrite Reumatoide/genética , Artrite Reumatoide/metabolismo , Artrite Reumatoide/patologia , Northern Blotting , Western Blotting , Cromatografia de Afinidade , Ensaio de Imunoadsorção Enzimática , Fibroblastos/citologia , Fibroblastos/metabolismo , Células Gigantes/citologia , Células Gigantes/metabolismo , Humanos , Técnicas Imunoenzimáticas , Imunoprecipitação , Pneumopatias/genética , Pneumopatias/metabolismo , Pneumopatias/patologia , Metaloproteinase 14 da Matriz/genética , Pólipos Nasais/metabolismo , Pólipos Nasais/patologia , Doenças Nasais/genética , Doenças Nasais/metabolismo , Doenças Nasais/patologia , Osteoartrite/genética , Osteoartrite/metabolismo , Osteoartrite/patologia , RNA Mensageiro/genética , Reação em Cadeia da Polimerase em Tempo Real , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Inibidor Tecidual de Metaloproteinase-2/genéticaRESUMO
Nasal chondromesenchymal hamartoma (NCMH) is an extremely rare benign tumor arising in the sinonasal tract, predominantly involving infants and children. To date, only 27 cases are reported in the international literature and there have been no reported cases of malignant transformation. We present a 40-year-old female patient with nasal obstruction and bloody rhinorrhea. Computed tomography (CT) of the nose and paranasal sinuses confirmed a heterogeneous polypoid soft-tissue mass filling the nasal cavity and extending into the maxillary and ethmoid sinus. The patient underwent a complete radical resection. Histological and immunohistochemical analyses showed a portion of the mass was consistent with typical NCMH. However, some areas of mass exhibited cytological atypia, marked mitotic activity and foci of necrosis. The atypical mesenchymal spindle cells were immunoreactive for vimentin, CD99 and smooth muscle actin (SMA) diffusely. The cartilaginous cells were immunopositive for S-100 protein. Ki-67 index was high in atypical areas, accounting for 50%. A rapid mass recurrence was observed at the original site only 3 months after surgery. The final diagnosis of NCMH with malignant transformation was made. To our knowledge, this is the first report of malignant transformation occurring in an adult with NCMH. Although NCMH commonly develops in the neonate or young infants and exhibits benign histological appearance and favorable prognosis, there is a possibility of malignant transformation in adult patients. Thoroughly histological inspections are suggested to be necessary to accurately diagnose this tumor when it is encountered in adults.
Assuntos
Doenças das Cartilagens/diagnóstico , Transformação Celular Neoplásica/patologia , Hamartoma/diagnóstico , Doenças Nasais/diagnóstico , Adulto , Doenças das Cartilagens/genética , Doenças das Cartilagens/metabolismo , Doenças das Cartilagens/cirurgia , Condrossarcoma Mesenquimal/diagnóstico , Diagnóstico Diferencial , Feminino , Hamartoma/genética , Hamartoma/metabolismo , Hamartoma/cirurgia , Humanos , Hibridização in Situ Fluorescente , Cavidade Nasal/patologia , Cavidade Nasal/cirurgia , Doenças Nasais/genética , Doenças Nasais/metabolismo , Doenças Nasais/cirurgia , Neoplasias Nasais/diagnóstico , Sarcoma/diagnósticoRESUMO
Both inferior turbinate hypertrophy and nasal polyp formation entail the enlargement of the nasal mucosa caused by rhinosinusitis, but their macro/microscopic and clinical findings differ markedly. This study aimed at investigating differences in the expressions of erbB1/2 and the tight junction proteins, claudin-1 and tricellulin, in the two tissues. Ten inferior turbinates and ten nasal polyps were collected. The expressions of erbB1/2, claudin-1, and tricellulin were examined by fluorescence immunohistochemistry and by quantitative real-time transcription-polymerase chain reaction (qRT-PCR). The eosinophil count and % of nasal gland area in the mucosa were also measured. The fluorescence intensities in the inferior turbinates were higher for erbB1/2 and lower for claudin-1 than those in the nasal polyps. The results of qRT-PCR were consistent with the immunohistochemical findings for erbB1/2. The quantity of tricellulin mRNA was significantly higher in the inferior turbinates than in the nasal polyps. The % of nasal gland area was significantly higher but the eosinophil count was significantly lower in the inferior turbinate than in the nasal polyp. These results suggest that the underlying pathogenesis of hypertrophic inferior turbinates and nasal polyps is likely to differ with respect to regeneration/proliferation and thus the remodeling process.
Assuntos
Receptores ErbB/metabolismo , Pólipos Nasais/metabolismo , Doenças Nasais/metabolismo , Receptor ErbB-2/metabolismo , Proteínas de Junções Íntimas/metabolismo , Conchas Nasais , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Claudina-1/genética , Claudina-1/metabolismo , Receptores ErbB/genética , Feminino , Perfilação da Expressão Gênica , Humanos , Hipertrofia/genética , Hipertrofia/metabolismo , Imuno-Histoquímica , Proteína 2 com Domínio MARVEL/genética , Proteína 2 com Domínio MARVEL/metabolismo , Masculino , Pessoa de Meia-Idade , Mucosa Nasal/metabolismo , Pólipos Nasais/genética , Doenças Nasais/genética , Reação em Cadeia da Polimerase em Tempo Real , Receptor ErbB-2/genética , Proteínas de Junções Íntimas/genética , Adulto JovemAssuntos
Face/microbiologia , Infecção por Mycobacterium avium-intracellulare/microbiologia , Doenças Nasais/microbiologia , Antígenos CD/metabolismo , Antígenos de Diferenciação Mielomonocítica/metabolismo , Feminino , Humanos , Pessoa de Meia-Idade , Complexo Mycobacterium avium/isolamento & purificação , Infecção por Mycobacterium avium-intracellulare/metabolismo , Infecção por Mycobacterium avium-intracellulare/patologia , Cavidade Nasal/microbiologia , Doenças Nasais/metabolismo , Doenças Nasais/patologia , Vimentina/metabolismoAssuntos
Doenças Nasais/tratamento farmacológico , Corticosteroides/administração & dosagem , Animais , Carcinoma , Doença Crônica , Displasia Fibrosa Óssea/diagnóstico , Humanos , Camundongos , Lavagem Nasal , Pólipos Nasais/tratamento farmacológico , Pólipos Nasais/metabolismo , Carcinoma Nasofaríngeo , Neoplasias Nasofaríngeas/cirurgia , Doenças Nasais/metabolismo , Osteíte/microbiologia , Osteoma/diagnóstico , Rinite/tratamento farmacológico , Rinite/metabolismo , Terapia de Salvação/métodos , Sinusite/tratamento farmacológico , Sinusite/metabolismo , Crânio/anatomia & histologia , Crânio/cirurgia , Osso Esfenoide/microbiologia , Transtornos Relacionados ao Uso de Substâncias/complicaçõesRESUMO
OBJECTIVE: To study the clinicopathologic features and differential diagnosis of extranodal Rosai-Dorfman disease (RDD) of the upper respiratory tract. METHODS: The clinical, pathologic and immunohistochemical features of 10 cases of RDD were evaluated. RESULTS: Among the 10 cases studied, there were 3 males and 7 females. The age of patients ranged from 20 to 61 years old (mean 38 years). The lesion arose in the nasal cavity (7 cases), nasopharynx (2 cases) or hard palate to trachea (1 case). Most of the patients presented with nasal obstruction, rhinorrhagia or tumor mass in the nasal/nasopharyngeal regions. CT scan often showed the presence of soft tissue lesion without bone destruction. Histologically, extranodal RDD was characterized by light-staining bands alternating with dark-staining bands. The light-staining bands were formed by aggregates of large round or polygonal histiocytes with emperipoiesis. The dark-staining bands were formed by abundant lymphoplasmacytic infiltrates. Immunohistochemical study showed that the histiocytes strongly expressed S-100 protein and partially expressed CD68. Six patients had no recurrence after surgical resection. CONCLUSIONS: Extranodal RDD of the upper respiratory tract is a rare disorder of histiocytic proliferation, which usually involves the nasal cavity and paranasal sinuses. RDD can easily mimic rhinoscleroma, mainly due to the overlapping morphologic appearance. Immunohistochemical study is helpful in the differential diagnosis.
Assuntos
Histiocitose Sinusal/patologia , Cavidade Nasal , Doenças Nasais/patologia , Adulto , Antígenos CD/metabolismo , Antígenos de Diferenciação Mielomonocítica/metabolismo , Diagnóstico Diferencial , Feminino , Seguimentos , Sarcoma Histiocítico/metabolismo , Sarcoma Histiocítico/patologia , Histiocitose de Células de Langerhans/metabolismo , Histiocitose de Células de Langerhans/patologia , Histiocitose Sinusal/diagnóstico por imagem , Histiocitose Sinusal/metabolismo , Histiocitose Sinusal/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Cavidade Nasal/patologia , Doenças Nasofaríngeas/diagnóstico por imagem , Doenças Nasofaríngeas/metabolismo , Doenças Nasofaríngeas/patologia , Doenças Nasofaríngeas/cirurgia , Neoplasias de Tecido Muscular/metabolismo , Neoplasias de Tecido Muscular/patologia , Doenças Nasais/diagnóstico por imagem , Doenças Nasais/metabolismo , Doenças Nasais/cirurgia , Proteínas S100/metabolismo , Tomografia Computadorizada por Raios X , Adulto JovemAssuntos
Histiocitose Sinusal/patologia , Doenças Nasais/patologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antígenos CD/metabolismo , Antígenos de Diferenciação Mielomonocítica/metabolismo , Criança , Diagnóstico Diferencial , Feminino , Seguimentos , Histiocitose Sinusal/diagnóstico por imagem , Histiocitose Sinusal/metabolismo , Histiocitose Sinusal/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Nasais/diagnóstico por imagem , Doenças Nasais/metabolismo , Doenças Nasais/cirurgia , Neoplasias Nasais/metabolismo , Neoplasias Nasais/patologia , Plasmocitoma/metabolismo , Plasmocitoma/patologia , Recidiva , Rinoscleroma/metabolismo , Rinoscleroma/patologia , Proteínas S100/metabolismo , Tomografia Computadorizada por Raios X , Adulto JovemRESUMO
Trichodiscomas are hamartomatous lesions of the follicular unit and of its surrounding stroma composed of epithelial and mesenchymal tissue elements. The dominating tissue element in trichodiscoma is the central fibrous stroma, encircled by prominent clusters of sebaceous lobules that resemble mitts. Rare variants of trichodiscomas with CD34-positive spindle cell-pedominant stroma have been described. We report a case of spindle cell-predominant trichodiscoma with prominent pseudosarcomatous/ancient features consisting in numerous large atypical spindle cells with frequent multinucleation, with no mitotic activity. The cytological changes were similar to those described in ancient schwannoma and symplastic hemangioma. We propose to call this lesion symplastic trichodiscoma. Only 1 previous case of fibrofolliculoma with pseudosarcomatous/ancient changes has already been reported. Although such lesions can appear worrisome at first glance, their benign evolution, the absence of mitosis, and the phenotypic studies excluding malignant differential diagnoses like atypical fibroxanthoma are reassuring. The precise pathogenesis of the symplastic features in schwannoma as in trichodiscoma/fibrofolliculoma is not known yet.
Assuntos
Doenças do Cabelo/patologia , Hamartoma/patologia , Doenças Nasais/patologia , Antígenos CD/análise , Antígenos CD/biossíntese , Doenças do Cabelo/metabolismo , Hamartoma/metabolismo , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Doenças Nasais/metabolismoRESUMO
OBJECTIVE: To critically and systematically review the data available on the sinonasal application of nasal nitric oxide measurement, particularly its use as a diagnostic, prognostic, or treatment effect indicator. DATA SOURCES: EMBASE 1980 to February 10, 2010; Medline 1950 to February 10, 2010; Cochrane Collaboration database; NHS Evidence Health Information Resources database. Review Methods. The databases were searched using a search strategy designed to include manuscripts relevant both to nitric oxide measurement and sinus or nasal problems. A title search was carried out on these manuscripts to select those relevant to clinical or basic science aspects of nitric oxide measurement. A subsequent abstract search selected those manuscripts concerning the application of nitric oxide measurement to sinonasal problems. The manuscripts selected were subject to a full-text review to extract data sets of nasal nitric oxide readings for different patient groups. RESULTS: Initially, 1088 manuscripts were selected. A title search found 335 manuscripts of basic scientific or clinical interest. An abstract search found 35 manuscripts directly relating to nitric oxide measurement in sinonasal disease. Full-text analysis produced 20 studies with extractable data on nasal nitric oxide levels in clearly defined patient groups. Studies did not show sufficient homogeneity to enable substantial meta-analysis of aggregated data. CONCLUSION: Current evidence shows that nasal nitric oxide is not a clinically useful measure for sinonasal disease. Although there is some evidence that sinus surgery is associated with lowered nasal nitric oxide levels, there is no evidence that this is associated with deterioration in sinus health.